Satellos Bioscience Stock Net Income
| MSCLF Stock | USD 0.48 0.03 5.88% |
Fundamental analysis of Satellos Bioscience allows traders to better anticipate movements in Satellos Bioscience's stock price by examining its financial health and performance throughout various phases of its business cycle.
Satellos |
Satellos Bioscience OTC Stock Net Income Analysis
Satellos Bioscience's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Satellos Bioscience Net Income | (15.51 M) |
Most of Satellos Bioscience's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Satellos Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Satellos Bioscience reported net income of (15.51 Million). This is 104.54% lower than that of the Healthcare sector and 122.14% lower than that of the Biotechnology industry. The net income for all United States stocks is 102.72% higher than that of the company.
Satellos Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Satellos Bioscience's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Satellos Bioscience could also be used in its relative valuation, which is a method of valuing Satellos Bioscience by comparing valuation metrics of similar companies.Satellos Bioscience is currently under evaluation in net income category among its peers.
Satellos Fundamentals
| Return On Equity | -0.86 | |||
| Return On Asset | -0.4 | |||
| Current Valuation | 7.17 M | |||
| Shares Outstanding | 41.8 M | |||
| Shares Owned By Insiders | 9.30 % | |||
| Shares Owned By Institutions | 14.41 % | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 295.34 X | |||
| Gross Profit | (793.97 K) | |||
| EBITDA | (4.49 M) | |||
| Net Income | (15.51 M) | |||
| Cash And Equivalents | 1.93 M | |||
| Cash Per Share | 0.06 X | |||
| Current Ratio | 1.04 X | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (5.03 M) | |||
| Earnings Per Share | (0.47) X | |||
| Market Capitalization | 15.29 M | |||
| Total Asset | 12.59 M | |||
| Net Asset | 12.59 M |
About Satellos Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Satellos Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Satellos Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Satellos Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price | |
| PRFDX | T Rowe Price | |
| RPBAX | T Rowe Price |
Other Information on Investing in Satellos OTC Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.